Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Hofseth Biocare ASA (HOFBF)

OTHER OTC:HOFBF

HOFBF

Hofseth Biocare ASA

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding HOFBF?

Track your performance easily

Link Broker

Hofseth Biocare ASA (HOFBF) Income Statement

5 Followers

Hofseth Biocare ASA Income Statement

Last quarter (Q4 2022), Hofseth Biocare ASA's total revenue was kr33.61M, an increase of 28.87% from the same quarter last year. In Q4, Hofseth Biocare ASA's net income was kr-38.27M. See Hofseth Biocare ASA’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	kr 120.45M	kr 120.45M	kr 87.62M	kr 69.25M	kr 67.78M	kr 60.74M
Cost of Revenue	kr 91.93M	kr 91.93M	kr 64.52M	kr 39.53M	kr 59.57M	kr 48.36M
Gross Profit	kr 28.51M	kr 28.51M	kr 23.10M	kr 29.72M	kr 8.21M	kr 12.38M
Operating Expense	kr 157.13M	kr 157.13M	kr 141.66M	kr 121.95M	kr 88.56M	kr 90.86M
Operating Income	kr -128.62M	kr -128.62M	kr -118.56M	kr -92.23M	kr -80.35M	kr -78.48M
Net Non Operating Interest Income Expense	kr -9.30M	kr -9.30M	kr -8.78M	kr -8.66M	kr -8.06M	kr -3.62M
Other Income Expense	-	-	-	-	-	-
Pretax Income	kr -137.39M	kr -137.39M	kr -126.46M	kr -102.09M	kr -89.22M	kr -84.53M
Tax Provision	-	kr 0.00	kr 0.00	kr 0.00	kr 0.00	kr 249.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr -137.39M	kr -137.39M	kr -126.46M	kr -102.09M	kr -89.21M	kr -84.77M
Basic EPS	kr -0.37	kr -0.37	kr -0.35	kr -0.31	kr -0.29	kr -0.33
Diluted EPS	kr -0.37	kr -0.37	kr -0.35	kr -0.31	kr -0.29	kr -0.33
Basic Average Shares	kr 1.50B	kr 374.74M	kr 357.83M	kr 333.65M	kr 308.45M	kr 259.97M
Diluted Average Shares	kr 1.52B	kr 374.74M	kr 357.83M	kr 333.65M	kr 308.45M	kr 259.97M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	kr 3.95M	kr 2.61M	kr 1.43M	kr 980.00K	kr 9.19M
Total Expenses	kr 249.06M	kr 249.06M	kr 206.18M	kr 161.48M	kr 148.13M	kr 139.22M
Net Income From Continuing And Discontinued Operation	kr -137.39M	kr -137.39M	kr -126.46M	kr -102.09M	kr -89.21M	kr -84.77M
Normalized Income	kr -137.39M	kr -137.39M	kr -126.46M	kr -102.24M	kr -89.41M	kr -83.72M
Interest Expense	kr 9.95M	kr 9.95M	kr 9.39M	kr 9.21M	kr 8.57M	kr 3.83M
EBIT	kr -127.44M	kr -127.44M	kr -117.07M	kr -92.88M	kr -80.64M	kr -80.70M
EBITDA	kr -97.02M	kr -97.02M	kr -87.72M	kr -66.11M	kr -53.19M	kr -58.51M

Currency in NOK

Hofseth Biocare ASA Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing